Overview

Dose of Magnesium Sulfate Infusion in Obese

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:
0

Participant gender:
All

Summary

Magnesium sulfate has been shown to be a successful tool in a large number of clinical areas. Its benefits include neuroprotection, control of eclampsia / pre-eclampsia, control of intraoperative blood pressure, decreased neuroendocrine response during laryngoscopy and tracheal intubation and reduced levels of postoperative pain and consumption of analgesic. Obese patients have become more and more frequent in the operating rooms, due to the increasing prevalence of this population worldwide. However, although they have received magnesium sulfate as part of the analgesic strategy in many centers, there has been no study demonstrating the appropriate dose of this medication in obese patients. This study aims to compare two doses of magnesium sulfate in obese patients: based on their real weight or based on ideal weight.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

University of Sao Paulo General Hospital

Treatments:

Magnesium Sulfate

Criteria

Inclusion Criteria: healthy patients, patients with controlled systemic disease (arterial
hypertension, endocrine disease), obese patients.

-

Exclusion Criteria: heart block, illicit drugs use, with neuropsychiatric impairment, in
blockers calcium channels and with renal impairment